Hoffer, L. John, Arlene Taveroff, and Alicia Schiffrin. Metabolic adaptation to protein restriction in insulindependent diabetes mellitus. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E59-E67, 1997.-Eight normal subjects, four subjects with intensively treated insulin-dependent diabetes mellitus (IDDM), and six subjects with conventionally treated IDDM consumed a test meal of 0.5 g protein and 10 kcal per kg body weight, first while adapted to a conventional diet high in protein, and then again after 5 days of dietary protein restriction.
Metabolic N balance (N consumed minus urea production) and net protein utilization were measured over the 9 h after consumption of the test meal, as was recovery in urea of 15N from a tracer dose of [15N] alanine included in each test meal. After the first test meal, N balance and net protein utilization were similar and close to zero for all groups. After the second test meal, N balance and net protein utilization became positive for all groups (P < 0.05) but significantly less so (P < 0.05) for the conventionally treated than for the normal and intensively treated diabetic subjects. 15N recovery in urea was reduced for all groups after the second test meal (P < 0.05) but probably less effectively (P < 0.09) for the conventionally treated diabetic subjects. Metabolic adaptation to protein restriction may be less effective than normal in conventionally treated IDDM. amino acids; nutrition; protein requirement; urea SUCCESSFUL ADAPTATION to a reduced protein intake requires both efficient recycling of the endogenous free amino acids released through proteolysis and efficient capture of dietary amino acids on their consumption in meals. In one well-studied procedure, the rate of body N loss is measured after several days of adaptation to a protein-free diet. This "obligatory N" indicates the lowest rate to which endogenous amino acid catabolism can be reduced, and hence the minimum amount needed to replace it from the diet (14) . Although highly precise, this measurement does not take into account the efficiency with which dietary amino acids are retained during their initial absorption and distribution within the tissues (23). Thus current estimates set the average adult requirement for high-quality protein substantially higher than is indicated by obligatory N loss: 0.60 vs. 0.34 g/kg adult body weight (14) .
Although it is clear that both efficient endogenous protein conservation and fed-state dietary amino acid retention are important determinants of the minimum protein requirement, there is little detailed knowledge about the mechanisms that govern the adaptation that maximizes their efficiency. In particular, a better understanding of hormonal effects on fed-state amino acid retention would provide important practical information about protein requirements in health and disease.
We previously obtained evidence that normal insulin economy is necessary to minimize endogenous amino acid catabolism by measuring obligatory urinary N of patients with insulin-dependent diabetes mellitus (IDDM) (20) . This finding is clinically relevant, because diabetic persons have been advised to limit their protein intake to retard the development of diabetic nephropathy (2). The present study was carried out to learn whether diabetes also prevents the increased efficiency of dietary amino acid retention necessary for successful adaptation to protein restriction. Normal and diabetic subjects consumed a mixed test meal of constant composition after adaptation, first, to a control diet generous in protein, and then once again after a period of adaptation to a protein-deficient diet that calls for increased efficiency of fed-state amino acid retention (17). Dietary amino acid retention was measured as postprandial N balance and net protein utilization (NPU), the fraction of N in the test meal retained in the body over the 9 h after meal consumption. In addition, a trace amount of [l"N]alanine was included in each test meal as a potential indicator of immediate or "first-pass" dietary amino acid catabolism and to calculate whole body protein synthesis and breakdown.
MATERIALS AND METHODS
Research subjects and metabolic control of diabetes. Eight nondiabetic adults (4 men and 4 women) and 10 subjects with C-peptide-negative IDDM were admitted to the Clinical Investigation Unit of the Royal Victoria Hospital. All subjects spent the duration of the study in this unit, where they maintained a constant, sedentary level of activity. Written informed consent was obtained in accordance with the regulations of the Ethics Committee of the Department of Medicine, Royal Victoria Hospital.
Four IDDM subjects (3 men and 1 woman) were assigned to an intensive insulin treatment (IIT) regimen, and six other subjects (4 men, 2 women) remained on conventional insulin therapy (CIT). The latter consisted of combined short-and intermediate-acting insulin before breakfast and supper, as used by the majority of individuals with IDDM. Blood glucose of the IIT subjects was controlled by a continuous subcutaneous infusion that provided short-acting insulin in up to four "basal" infusion rates over the day, plus "bolus" injections to cover the nutrients provided in meals (MiniMed Technologies, Sylmar, CA). For these patients the aim was to achieve premeal capillary blood glucose concentrations between 4 and 7 mmol/l and 2-h postprandial concentrations of <IO mmol/l (9). Capillary blood glucose was measured in the diabetic subjects seven times daily with use of Chemstrip bG glucose oxidase reagent test strips and the AccuChek II blood glucose monitor (Boehringer Mannheim Canada, Dorval, QC). The diabetic subjects were admitted to the metabolic unit 2-4 days earlier than the normal subjects to establish targeted metabolic control before the 1st day of . Four normal and five diabetic subjects also consumed a tracer dose of [13C]urea (99.3% 13C, MSD Isotopes; 500 mg for 7 subjects and 200 mg for 2 subjects). Blood samples were drawn into heparinized tubes every 30 min for 4 h and at hours 5, 6, and 9 to measure glucose, urea, Cakulations. Urea appearance was calculated as total urinary urea excretion over the 9 h after start of the test meal, with an appropriate addition or subtraction to account for increased or decreased urea in body water over this time period (1, 21). Total body water was estimated from age, height, and weight (1). Hourly urea appearance was calculated in the same manner from hourly urinary excretion and plasma concentrations.
Plasma urea concentrations were fitted to the smoothing function u(t) = a + bx + cx2 + dx3 + ex4, where u(t) is plasma urea and t is time (Graph Pad Inplot 4.0, San Diego, CA), to avoid exaggerated effects of small analytic variation in the determinations.
No correction was made for unmeasured urea losses into gut water, but the importance of this effect was estimated by measuring the recovery, in total body water and urine, of the known dose of 
RESULTS
Subject characteristics and diabetes control. The subjects were nonsmokers with stable body weight and normal health apart from diabetes (see Table 1 ). The diabetic subjects were free of clinically evident complications of diabetes such as renal, visual, vascular, neurological, or gastrointestinal impairment. Before their admission to the unit, nine diabetic subjects followed a conventional twice-daily insulin regimen, and one man, who was allocated to the IIT group, had used a combination of long-acting insulin with shortacting coverage for each meal. Figure 1A illustrates mean daily blood glucose concentrations of the diabetic subjects over the 11 days of the formal study. As calculated over the final 3 days of each dietary period, average daily blood glucose of the IIT subjects was 7.5 * 0.2 mmol/l on the high-protein diet and 6.3 t 0.4 mmol/l on the low-protein diet. Corresponding values for the CIT group were significantly higher: 11.3 t 0.8 mmol/l (high-protein diet; P < 0.01) and 10.2 t 1.0 mmol/l (low-protein diet; P < 0.05). The attainment of comparable levels of glycemia throughout the study required a steady reduction of the daily insulin dose soon after switching to the low-protein diet (Fig. 1B) . The average insulin dosage had to be reduced by 2.9 ? 0.3 U/day (P < 0.001) in the IIT subjects and by 4.2 ? 0.6 U/day in the CIT subjects (P < 0.01). We have previously noted the effect of protein restriction to reduce insulin requirements in other IDDM subjects (19).
Energy and nitrogen balance. Measured resting energy expenditure of the control subjects was 1,478 t 60 kcal/day, 96% of the predicted value (15) 4-L z 2--x I I I I, I II I I I 1 2 3 4 5 6 7 8 9 10 11 expenditure of the CIT subjects was virtually the same as predicted (1,773 _ + 146 kcal./day measured, 1,725 ? 78 kcal/day predicted), that of the IIT subjects (1,560 ? 77 kcal/day) was 11% lower than predicted (1,750 t 42 kcal./day; P < 0.05). The effect of IIT to reduce resting energy expenditure has been observed previously (7). The CIT subjects lost 171 t 33 kcal/day as glycosuria during the high-protein diet but only 59 * 20 kcal/day during the period of protein restriction (P < 0.05). Urinary energy losses by the IIT subjects were 25 ? 11 kcal/day on the high-protein diet and 8 t 4 kcal/day during protein restriction (P < 0.05). Resting energy expenditure was unaffected by the low-protein diet. Mean body weight did not change significantly for any group during either the high-or low-protein periods. Mean coefficient of variation in daily urinary creatinine excretion, a measure of the accuracy of the 24-h urine collections, was 6.0 I~I 0.8%. N balance was constant and close to zero for all subject groups while on the baseline diet and became equally negative after protein restriction (Fig. 2) . Test meal response. The first test meal increased blood glucose of the IIT subjects from 4.5 t 0.5 to 7.5 t 0.9 mmol/l 2 h later (Fig. 3) . The response was similar on the 2nd study day, increasing from a fasting value of 4 3 + 0 6 to 6 1 t 0.3 mmol/l 2 h later. Fasting blood . -. glucose and its postprandial increase were significantly greater than normal for the CIT subjects (P < O. increasing from 10.0 t 1.4 mmol/l before the test meal to 16.9 t 0.8 mmol/l 2.5 h later. Their response to the second test meal was closely similar. Plasma insulin (measured only in the normal subjects) was 100 pmol/l before both test meals, rose to 500-600 pmol/l at 1 h, and fell to 400 pmol/l at 2 h and 200 pmol/l at 3 h after the test meal, with no difference between the meals. Fasting plasma glucagon concentrations were similar for all three groups and showed a similar postprandial increment after both test meals (Fig. 4) . Before the first test meal, plasma leucine was 125 t 4, 109 t 7, and 128 t 9 umol/l for the normal, IIT, and CIT groups, respectively (NS), rising to 199 2 8,271 t 16, and 266 t 16 umol/l, respectively (P < O.OOOl), by 1.5 h after the test meal; the postprandial increase was significantly higher than normal for both IDDM groups (P < 0.01). After protein restriction, fasting plasma leucine was reduced equivalently for all three groups (99 + 7, 98 + 7, and 108 t 8 umol/l, respectively; P < O.OOil), rising to 205 t 9, 239 2 23, and 253 t 12 umol/l, respectively, 1.5 h after the second test meal. The postprandial rise was only slightly higher for the diabetic groups than for the normal group (P = 0.07; Fig. 5 ). Valine concentrations showed a closely similar pattern (data not shown).
Before the first test meal, fasting plasma alanine concentrations were 336 t 22,357 ? 40, and 327 t 27 umol/l for the normal, IIT, and CIT groups, respectively (NS), rising (P < 0.0001) to 486 5 33, 492 t 36, and 554 ? 29 umol/l, respectively, by 1.5 h after the test meal (NS). After 5 days of protein restriction, fasting plasma alanine had increased (P < 0.0001) equivalently in all three groups to 505 2 66, 539 t 79, and 505 -+ 66 umol/l, increasing further (P < 0.0001) by 1.5 h after the second test meal to 754 2 60, 739 ? 89, and 784 t 57 pmol/l, respectively (Fig. 5) . Before the first test meal, fasting plasma glutamine + glutamate concentrations were 638 5 30, 649 t 20, and 625 t 23 umol/l for the normal, IIT, and CIT groups, respectively (NS), rising (P < 0.0001) by 1.5 h after the test meal to 722 ? 33, 743 -+ 35, and 768 ? 32 pmol/l, respectively. After 5 days of protein restriction, fasting plasma glutamine + glutamate increased for all three groups to 793 t 53, 838 t 23, and 938 t 94 pmol/l (P < O.OOOl), rising yet further (P < 0.0001) by 1.5 h after consumption of the second test meal to 910 t 70,946 t 57, and 1,145 t 110 umol/l, respectively, without significant differences among the groups. Urea N appearance after the first test meal was similar for all three groups, indicating near-zero metabolic N balance and zero NPU (Table 3 and Fig. 6 ). After the second test meal, urea excretion was significantly reduced and NPU significantly increased for all groups (P < 0.05). Ho wever, whereas urea N appearance of the IIT subjects was reduced to a value close to that of the normal subjects, that of the CIT group remained 19% higher (P < 0.05). As a result, postprandial N balance of the CIT subjects was significantly less positive after the second test meal than in the normal group and their NPU significantly less improved (Table 3) .
Dater metabolism. The distribution of dietary 15N in the free amino N pool was monitored in plasma alanine, glutamine + glutamate, leucine, and valine. Plasma [15N] alanine enrichment increased equivalently for all subject groups after both test meals, reaching a maximum of -08APE after 1.5 h; however, between 1.5 and 9 h, the rate of declining enrichment was slower on the second test day for all groups (P < 0.05, Fig. 7 ). Plasma glutamine + glutamate 15N enrichment rose to a maximum of -0.3 APE and then declined, with a time profile similar to that of alanine 15N enrichment and with no important difference among groups or between studies (Fig. 7) . Plasma leucine and valine 15N enrichments rose slowly and steadily after the test meal in all the studies to levels of -0.1-0.2 APE (data not shown).
After the first test meal, -25% of the 15N included in it was recovered after 9 h in [15N]urea in urine and body water, with no significant difference among the subject groups ( recovery in urea was greatly reduced for all groups (P < 0.05), but more greatly for the normal and IIT subjects. The lower recovery of the normal subjects (16.3 t 1.6%) than the CIT subjects (20.6 t 1.6%) is borderline statistically significant (P < 0.09), but if the recovery of the normal and IIT groups is combined, as may be justified because their urea metabolism was otherwise closely similar, the resulting recovery (14.7. t 1.5%) is significantly lower than for the CIT subjects (P < 0.05).
Q, S, and B were similar in the three groups after the first test meal. Q was 263 t 25,338 t 42, and 257 t 9 mg N l kg-l l 9 h-l, respectively, for the normal, IIT, and CIT groups (NS), whereas S was 193 2 26, 272 2 44, and 180 ? 11 mg Ne kg-l.9 h-l and B was 183 t 25, 257 t 42, and 177 t 9 mg N-kg-l 09 h-l, respectively. Q and B increased insignificantly from the first to the second test meal. (Q was 310 t 22,448 I~I 78, and 283 t 16 mg N-kg-l-9 h-l for normal, IIT, and CIT groups, respectively; B was 229 ? 22, 368 t 78, and 202 t 16 mg N*kg-l*9 h-l, respectively.) However, after the second test meal, S increased significantly for both the normal and CIT groups: 262 t 23 and 225 t 17 mg N*kg-l-9 h-l, re spectively (P < 0.05 compared with the first test meal); S was higher as well for the IIT subjects (402 ? 83 mg No kg-l 09 h-l?, but this was not statistically significant.
Recovery of the [13C]urea included in both test meals of four normal and five CIT subjects was measured to determine whether the diets or diabetes affected the fraction of newly synthesized urea lost in the gut or elsewhere. There was no significant effect of either diet There are no significant differences among groups or between studies. 
DISCUSSION
This study tested whether persons with IDDM appropriately reduce postprandial amino acid catabolism when their protein intake is restricted. After adaptation to the control diet, which was generous in protein, both the normal and diabetic subjects responded to the test meal appropriately with near-zero fed-state metabolic N balance. When the test meal was preceded by 5 days of protein restriction, postprandial urea production of the normal and IIT subjects was substantially reduced, but the response of the CIT subjects was significantly less effective.
Our study aimed to reproduce clinical IIT and CIT of IDDM as realistically as possible. In the recently completed Diabetes Control and Complications Trial (IO), average daily blood glucose was 12.8 mmol/l during CIT and 8.6 mmol/l during IIT, average fasting and postbreakfast prandial glucose values of IIT patients were 8.0 and 10.4 mmol/l, and average fasting and postbreakfast glucose values of CIT patients were 11.1 and 15.1 mmol/l. The glycemic control established in our treatment groups is in agreement with this, suggesting that our results are applicable to clinical practice. We therefore suggest that there is no adverse nutritional consequence to CIT or IIT in adults with IDDM when protein consumption is above 1 go kg-l l day-l; however, during protein restriction, persons with conventionally treated IDDM may be at increased greater risk of malnutrition.
Most evidence indicates that protein metabolism deteriorates gradually as tissue insulin availability diminishes. Severe insulin deficiency increases whole body proteolysis and amino acid catabolism in a dramatic fashion that is largely, although perhaps not Fig. 6 . Urea N response to test meals after adaptation to high-protein diet (first test meal, A) and then to lowprotein diet (second test meal, B) in normal subjects (0) and subjects with intensively (m) and conventionally (+> treated IDDM. Urea N appearance in conventionally treated group was significantly higher than normal after the second test meal (P < 0.05). entirely (4), independent of dietary protein intake. By contrast, CIT combined with adequate nutrition has long been known to reverse and prevent protein wasting in IDDM (5), even though subtle abnormalities of amino acid metabolism may persist. Thus, in metabolic studies, insulin infusions that reduced the blood glucose concentration to a level typical of CIT (10 mmol/l) were associated with abnormally high plasma leucine turnover and oxidation, several hours of euglycemia (5 mmol/l) being required to fully normalize these parameters of whole body amino acid metabolism (25, 34) . Clinical CIT has frequently been associated with increased circulating branched-chain amino acid concentrations (31). Indeed, the recognition that abnormalities of protein metabolism persist during CIT and the potential adverse effect this could have on the growth of diabetic children helped motivate the development of modern IIT (29, 31) . Even during IIT, obligatory N of IDDM subjects increases abnormally in direct proportion to modest deviations from strict euglycemia (20), suggesting that there is no clear level of insulin sufficiency above which protein metabolism is entirely normal and below which protein metabolism is suddenly impaired. Our results are from samples too small to permit accurate quantitation, but the magnitude of the effect they suggest, a 40% lower-than-normal fed-state N balance and NPU in protein-restricted CIT subjects, is nutritionally important. Indeed, there are several reasons why we may have underestimated the degree to which protein metabolic efficiency is impaired in the clinical situation. First, because negative energy balance prevents efficient amino acid utilization (14), we took special care to provide adequate dietary energy during this study, as confirmed by direct measurement of resting energy expenditure and the attainment of near-zero total N balance during the control diet period. Negative energy balance can occur in glycosuric IDDM, and the combination of energy deficiency and suboptimal insulin provision could have a greater protein catabolic effect than either condition alone. Second, the test meal was deliberately made generous in protein to distinguish the effects of prior nutritional adaptation from the immediate response to the test meal. During actual protein restriction there would be far less protein in meals than the 500 mg/kg in our test meal, and it is possible that the combination of inadequate adaptation and a low-protein meal would widen the difference between the normal and diabetic subjects observed in this study. Finally, we optimized basal insulin provision before the test meals, to the extent possible with CIT, to specifically assess the role of the insulin dose covering the test meal in regulating fedstate protein economy. The normal preprandial plasma Despite these potential sources of error, we believe our conclusions are valid, because metabolic N balance was equivalent for all subject groups under control conditions, despite hyperglycemia in the CIT group, and because detection of [13C]urea included as a recovery marker in the test meal was similar, 75%, for all subject groups on both study days.
[15N] alanine, a rapidly transaminated nonessential amino acid, was included in each test meal to assess the immediate metabolism of alanine N in the meal, and also, in our initial plan, to measure the parameters of whole body protein turnover, as in a previous study of brief protein restriction (32) . The N of dietary protein (28) or infused alanine (18, 36) is rapidly used for urea synthesis in humans, and in IDDM the conversion of alanine to urea is increased (1). After oral administration, most alanine N becomes rapidly available to label the splanchnic free amino acid pool (3). Tracing it could therefore indicate the extent to which amino acids absorbed from food are -immediately catabolized or retained within proteins.
After the isotope was administered, [15N] alanine plasma enrichment increased with a similar time profile on both study days for the three subject groups, despite the higher plasma alanine concentrations that resulted from the protein restriction.
After reaching its maximum, alanine enrichment decreased significantly more slowly after the second test meal than after the first (P < 0.05), suggesting similar initial [15N]alanine splanchnic absorption and availability for distribution into the periphery after both test meals, in a setting of slowed endogenous alanine removal on the 2nd study day. This interpretation is supported by the time course of plasma glutamine + glutamate enrichment, which also demonstrated comparable rates of rising enrichment on both study days. From these observations we regard it as unlikely that [l"N]alanine transamination to more immediate urea precursors was rate limiting for the transfer of the label into urea, and therefore that the smaller recovery of 15N in urea after the second test meal was due to decreased urea formation from a urea precursor pool that was equivalently labeled with 15N after both test meals. We propose that, after first-pass distribution of 15N from alanine into the splanchnic free amino N pool, an important fraction of this pool is spared from ureagenesis through sequestration within newly synthesized splanchnic or hepatic proteins, and that this protein-sparing process is impaired in IDDM. Recent reports on the effects of the fed state and IDDM on hepatic albumin synthesis strongly suggest that it serves this function in humans (l&12).
This explanation, if correct, casts doubt on the accuracy of the tracer end-product model for whole body N flux, at least as it was used in the present study. The single-dose end-product model (13) assumes that whole body N flux may be calculated from the equality Q/E = i/e, where E refers to total urea excretion, and i and e are, respectively, the dose of 15N administered and total 15N recovered after 9 h in urea in urine and body water. This model will overestimate Q (and hence S and B) if newly 15N-enriched amino acids are sequestered into new splanchnic protein synthesis before equilibrating in the whole body free N pool. We suggest that this occurred, and the evidence for it is the apparently higher S in the normal and CIT groups after the second test meal. The alternative, that protein restriction truly increases fed-state whole body protein turnover, would be at variance with current understanding of the adaptation to protein deficiency (35 
